Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Pers Med ; 12(4)2022 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-35455715

RESUMO

Neurodevelopmental disorders have steadily increased in incidence in the United States. Over the past decade, there have been significant changes in clinical diagnoses and treatments some of which are due to the increasing adoption of pharmacogenomics (PGx) by clinicians. In this pilot study, a multidisciplinary team at the Arkansas Children's Hospital North West consulted on 27 patients referred for difficult-to-manage neurodevelopmental and/or neurobehavioral disorders. The 27 patients were evaluated by the team using records review, team discussion, and pharmacogenetic testing. OneOme RightMed® (Minneapolis, MN, USA) and the Arkansas Children's Hospital comprehensive PGx test were used for drug prescribing guidance. Of the 27 patients' predicted phenotypes, the normal metabolizer was 11 (40.8%) for CYP2C19 and 16 (59.3%) for CYP2D6. For the neurodevelopmental disorders, the most common comorbid conditions included attention-deficit hyperactivity disorder (66.7%), anxiety disorder (59.3%), and autism (40.7%). Following the team assessment and PGx testing, 66.7% of the patients had actionable medication recommendations. This included continuing current therapy, suggesting an appropriate alternative medication, starting a new therapy, or adding adjunct therapy (based on their current medication use). Moreover, 25.9% of patients phenoconverted to a CYP2D6 poor metabolizer. This retrospective chart review pilot study highlights the value of a multidisciplinary treatment approach to deliver precision healthcare by improving physician clinical decisions and potentially impacting patient outcomes. It also shows the feasibility to implement PGx testing in neurodevelopmental/neurobehavioral disorders.

2.
Holist Nurs Pract ; 16(2): 32-9, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11845764

RESUMO

Members of the hospice team weave a tapestry of care with patients and families. Relief of suffering--physical, emotional, and spiritual--is the goal of hospice care. Nurses' contribution to that care is central but often seemingly unnoticed. Their contribution to the tapestry constitutes the subtle threads of the background upon which the tapestry evolves. Nurses' work is often viewed simplistically, and the complexity of simple tasks is hidden. Work examples of nurses in hospice are discussed, and the previously unseen yet central parts of nurses' work are highlighted.


Assuntos
Ética em Enfermagem , Cuidados Paliativos na Terminalidade da Vida/métodos , Papel do Profissional de Enfermagem , Cuidados de Enfermagem/métodos , Equipe de Assistência ao Paciente/normas , Luto , Continuidade da Assistência ao Paciente , Cuidados Paliativos na Terminalidade da Vida/psicologia , Cuidados Paliativos na Terminalidade da Vida/normas , Humanos , Cuidados de Enfermagem/normas , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA